Drug Report History #166024
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that have changed between versions will be highlighted in yellow, and the changes will be clearly marked as updated.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow, and the change will be clearly marked as updated.
| Field | Version v12-FR | Version v2-FR |
|---|---|---|
| Language | French | French |
| Date Updated | 2023-12-08 (Updated) | 2022-08-03 |
| Drug Identification Number | 02432463 | 02432463 |
| Brand name | LODALIS | LODALIS |
| Common or Proper name | LODALIS | LODALIS |
| Company Name | BAUSCH HEALTH, CANADA INC. | BAUSCH HEALTH, CANADA INC. |
| Ingredients | COLESEVELAM HYDROCHLORIDE | COLESEVELAM HYDROCHLORIDE |
| Strength(s) | 3.75G | 3.75G |
| Dosage form(s) | POWDER FOR SUSPENSION | POWDER FOR SUSPENSION |
| Route of administration | ORAL ORAL | ORAL ORAL |
| Packaging size | 30ct | 30ct |
| ATC code | C10AC | C10AC |
| ATC description | LIPID MODIFYING AGENTS, PLAIN | LIPID MODIFYING AGENTS, PLAIN |
| Reason for shortage | Shortage of an inactive ingredient or component. | Shortage of an inactive ingredient or component. |
| Anticipated start date | 2022-10-31 | 2022-10-31 |
| Actual start date | 2022-10-31 (Updated) | |
| Estimated end date | (Updated) | 2023-08-01 |
| Actual end date | 2023-12-01 (Updated) | |
| Shortage status | Resolved (Updated) | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | Discontinued (Updated) | |
| Health Canada comments |